Abstract:Proteolysis Targeting Chimeras (PROTACs) represent a promising therapeutic modality to address undruggable and resistant issues in drug discovery. However, potential on-target toxicity remains clinically challenging. We developed a generalized caging strategy to synthesize a series of stimuli-responsive PROTACs (sr-PROTACs) with diverse molecular blocks bearing robust and cleavable linkers, presenting "turn on" features in manipulating protein degradation. By leveraging pathological cues, such as elevated ROS, phosphatase, H2S, or hypoxia, and external triggers, such as ultraviolet light, X-Ray, or bioorthogonal reagents, we achieved site-specific activation and traceless release of original PROTACs through de-caging and subsequent self-immolative cleavage, realizing selective uptake and controlled protein degradation in vitro. An in vivo study revealed that two sr-PROTACs with phosphate- and fluorine-containing cages exhibited high solubility and long plasma exposure, which were specifically activated by tumor overexpressing phosphatase or low dosage of X-Ray irradiation in situ, leading to efficient protein degradation and potent tumor remission. With more reactive biomarkers to be screened from clinical practice, our caging library could provide a general tool to design activatable PROTACs, prodrugs, antibody-drug conjugates, and smart biomaterials for personalized treatment, tissue engineering or regenerative medicine.

Structure-Guided Design and Optimization of Covalent VHL-Targeted Sulfonyl Fluoride PROTACs

PROTACs: an Emerging Targeting Technique for Protein Degradation in Drug Discovery

Covalent PROTAC Design Method Based on a Sulfonyl Pyridone Probe

Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel–Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7

Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry

Chemistries of bifunctional PROTAC degraders

In Vivo Target Protein Degradation Induced by PROTACs Based on E3 Ligase DCAF15

Applications of covalent chemistry in targeted protein degradation

Stimuli‐Responsive PROTACs for Controlled Protein Degradation

PROTAC-Design-Evaluator (PRODE): An Advanced Method for In-Silico PROTAC Design

Strategies for Designing Proteolysis Targeting Chimaeras (Protacs)

Small Molecule PROTACs in Targeted Therapy: an Emerging Strategy to Induce Protein Degradation.

Reversible Assembly of Proteolysis Targeting Chimeras

PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy

Affinity and cooperativity modulate ternary complex formation to drive targeted protein degradation

Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders

Novel Design Strategies to Enhance the Efficiency of Proteolysis Targeting Chimeras

Design and Synthesis of Proteolysis-Targeting Chimeras (protacs) As Degraders of Glutathione Peroxidase 4.

Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation

Protein Degradation Through Covalent Inhibitor-Based PROTACs.